MoneyWorks4Me

Lasa Supergenerics informs about disclosure of related party transactions

28 Nov 2022 Evaluate

Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, Lasa Supergenerics has informed that it enclosed Disclosure of Related Party Transactions for the half year ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..